4//SEC Filing
Marshall Keith W 4
Accession 0001209191-23-034038
CIK 0001718852other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 7:03 PM ET
Size
7.5 KB
Accession
0001209191-23-034038
Insider Transaction Report
Form 4
Marshall Keith W
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-06-02$3.10/sh+78,162$242,302→ 87,973 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-06-02−78,162→ 52,838 totalExercise: $3.10Exp: 2030-08-11→ Common Stock (78,162 underlying)
Footnotes (2)
- [F1]This transaction represents an exercise and hold of stock options by the Reporting Person for tax planning purposes.
- [F2]25% of the shares subject to the option vested and became exercisable on August 3, 2021, and 1/48th of the shares subject to the option vesting monthly thereafter, subject to the Report Person's continued service with the Issuer through each vest date.
Documents
Issuer
Prometheus Biosciences, Inc.
CIK 0001718852
Entity typeother
Related Parties
1- filerCIK 0001714828
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 7:03 PM ET
- Size
- 7.5 KB